Riskpilot← Back to searchSign inGet full accessMeditro Aktiebolag
ABActiveOrg 5566065271Vaxmoravägen 25 BWholesale of pharmaceutical and medical goods · NACE 4646Est. 20010 employees
Revenue 2024
SEK 3,1M
+3% vs 2023
EBITDA margin
-17.5%
-78% vs 2023
Equity ratio
5.2%
Financial strength
Net profit 2024
SEK 21K
+320% vs 2023
| Revenue | SEK 3,1M | +3% |
| EBITDA | SEK -539K | -78% |
| Net profit | SEK 21K | +320% |
| Total assets | SEK 5,7M | +188% |
| Equity | SEK 298K | +8% |
| Employees | 0 | — |
Legal name
Meditro Aktiebolag
Org number
5566065271
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13 februari 2001
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva uthyrning och handel med medicinsk utrustning inom och utom landet, likaledes bedriva handel med optiska varor. Bolaget skall även bedriva hälso- och ögonsjukvård, samt utbildning i anslutning därtill, ävensom idka därmed förenlig verksamhet.
Address
Vaxmoravägen 25 B
Phone
+4686289006
Email
christos.lenis@novius.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 490 | 4 007 | 4 397 | 3 008 | 3 086 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 848 | −62 | −65 | −303 | −539 |
| Depreciation & amort. | −133 | −186 | −160 | −160 | −136 |
| EBIT | 715 | −248 | −225 | −463 | −675 |
| Net financials | — | — | — | 2 | 2 |
| Profit before tax | 5 | 72 | 6 | 8 | 27 |
| Tax | −0 | −1 | −2 | −3 | −6 |
| Net profit | 5 | 71 | 4 | 5 | 21 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 560 | 1 041 | 857 | 1 973 | 5 685 |
| Equity | 2 097 | 268 | 272 | 277 | 298 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 463 | 773 | 585 | 1 696 | 5 387 |
| Total debt | 8 463 | 773 | 585 | 1 696 | 5 387 |
EBITDA margin
-17.5%
This company
15.8%
Market median
-211% vs market
20202024
Equity ratio
5.2%
This company
38.2%
Market median
-86% vs market
20202024
Return on equity
7.0%
This company
18.4%
Market median
-62% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20202024
Debt / equity
18.08×
This company
0.62×
Market median
-2816% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CJ Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Novius Holding AB
Meditro Aktiebolag Board members of Meditro Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Jacob Mattias Biderholt | Chief Auditor | 0 companies |
| Konstantinos Lenis | Board of Directors | 0 companies |
| Christos Lenis | Deputy Board Member | 0 companies |